HYPERKALAEMIA
Clinical trials for HYPERKALAEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERKALAEMIA trials appear
Sign up with your email to follow new studies for HYPERKALAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug aims to keep kidney patients out of the hospital
Disease control CompletedThis study tested whether continuing a potassium-lowering medication called SZC after hospital discharge helps people with chronic kidney disease better maintain safe potassium levels compared to standard care. It involved about 186 adults who were hospitalized for high potassium…
Matched conditions: HYPERKALAEMIA
Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Doctors track how a drug manages dangerous potassium levels
Knowledge-focused CompletedThis study aimed to understand how doctors in Greece treat patients with high potassium levels (hyperkalaemia) who also have kidney disease or heart failure. Researchers observed the real-world use of a medication called sodium zirconium cyclosilicate in about 120 patients over s…
Matched conditions: HYPERKALAEMIA
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Apr 02, 2026 01:56 UTC